Clinical Trials Directory

Trials / Completed

CompletedNCT01119196

The Measurement of Insulin Resistance in Peritoneal Dialysis Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this study is to examine the relevance of insulin resistance in peritoneal dialysis (PD) patients as well as the means to improve this metabolic derangement. We will do so through a prospective randomized study using Icodextrin as an alternate dialysate solution to routine glucose-based dialysate. We hypothesize that (1) the glucose loading associated with PD leads to impairment in insulin sensitivity, (2) the degree of insulin resistance is dependent on the basal metabolic state (fasting versus stimulated), and (3) the replacement of conventional dialysate with glucose-sparing dialysate preparations will improve insulin resistance and associated metabolic disturbances in PD patients.

Conditions

Interventions

TypeNameDescription
OTHERIcodextrin dialysateuse of alternate SOC dialysate

Timeline

Start date
2010-09-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2010-05-07
Last updated
2016-09-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01119196. Inclusion in this directory is not an endorsement.

The Measurement of Insulin Resistance in Peritoneal Dialysis Patients (NCT01119196) · Clinical Trials Directory